National HealthCare stock (US6359061031): dividend raise and steady earnings keep long-term story in focus

National HealthCare recently lifted its quarterly dividend and reported solid full-year 2024 results, underscoring its role as a defensive healthcare operator for income-focused investors.

National HealthCare has attracted attention from income-oriented investors after reporting full-year 2024 results and announcing a higher quarterly dividend for 2025, reflecting resilient demand for its skilled nursing and senior care services, according to a company press release published on 02/16/2025 and the accompanying annual report released the same day National HealthCare investor update as of 02/16/2025.

As of: 17.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: National HealthCare Corporation
• Sector/industry: Healthcare, skilled nursing and senior care
• Headquarters/country: Murfreesboro, Tennessee, USA
• Core markets: Long-term care, skilled nursing, assisted living and senior housing in the United States
• Key revenue drivers: Skilled nursing facility occupancy, Medicare and Medicaid reimbursement, managed care and private pay services
• Home exchange/listing venue: NYSE American (ticker: NHC)
• Trading currency: USD

National HealthCare: core business model

National HealthCare operates a network of skilled nursing centers, assisted living facilities and other senior care services in the United States, focusing on post-acute, rehabilitative and long-term care for an aging population, as described in its 2024 annual report released on 02/16/2025 National HealthCare annual filing as of 02/16/2025.

The company’s revenue model is largely based on providing inpatient skilled nursing and rehabilitative services that are reimbursed by Medicare, Medicaid, managed care insurers and private payors, which exposes National HealthCare to changes in US healthcare policy and reimbursement rates but also gives it access to stable government-backed funding streams, according to its regulatory filings and investor materials released on 02/16/2025 National HealthCare Form 10-K as of 02/16/2025.

Beyond traditional skilled nursing services, National HealthCare also derives revenue from ancillary offerings such as homecare, hospice and rehabilitation therapy, which allow it to support patients along the care continuum and diversify its income sources, as outlined in its 2024 annual report published on 02/16/2025 National HealthCare business overview as of 02/16/2025.

Main revenue and product drivers for National HealthCare

For full-year 2024, National HealthCare reported that total operating revenues increased year over year, driven primarily by higher patient volumes and improved reimbursement rates in its skilled nursing centers, according to its annual results release dated 02/16/2025 National HealthCare results update as of 02/16/2025.

The company highlighted that occupancy levels in many of its skilled nursing facilities continued to recover compared with earlier pandemic periods, while labor cost pressures remained a key factor for margins, particularly in nursing and clinical staff, as described in management’s discussion of results in the 2024 Form 10-K filed on 02/16/2025 National HealthCare MD&A as of 02/16/2025.

In addition to traditional long-term care, National HealthCare’s therapy, homecare and hospice segments provided incremental revenue and allowed the group to balance exposure between government-funded and private-pay services, a diversification that management pointed to as supporting long-term stability in its 2024 annual report released on 02/16/2025 National HealthCare notes to financials as of 02/16/2025.

Why National HealthCare matters for US investors

National HealthCare is listed on NYSE American under the ticker NHC and gives US investors direct exposure to the skilled nursing and senior housing segment, which is closely tied to demographic trends such as the aging US population, according to its listing information and company overview updated on 02/16/2025 NYSE company profile as of 02/16/2025.

The company’s cash flows are significantly influenced by Medicare and Medicaid reimbursement frameworks, meaning that US healthcare policy developments, including rate updates and regulatory changes, can have a direct impact on earnings and valuation, as highlighted in the risk factors section of its 2024 Form 10-K filed on 02/16/2025 National HealthCare risk disclosure as of 02/16/2025.

For investors based in the US and abroad who are looking for defensive healthcare exposure denominated in US dollars, National HealthCare’s focus on essential long-term care services and its history of dividend payments are often viewed in the context of portfolio diversification and income generation, as referenced in its dividend announcement dated 02/16/2025 National HealthCare dividend release as of 02/16/2025.

Conclusion

National HealthCare combines a network of US skilled nursing and senior care facilities with a revenue base that leans on Medicare, Medicaid and private insurers, and its recent full-year 2024 results and dividend increase underscore both the opportunities and regulatory sensitivities of this model; for investors, the stock represents a focused way to participate in long-term demographic trends while remaining exposed to reimbursement policies, labor cost dynamics and operational execution.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.